Is Ampullary Cancer Hereditary? Genetic Testing Explained

Most cases of ampullary cancer are sporadic, meaning they have no known inherited predisposition and occur by chance. However, studies show that a meaningful percentage of people with ampullary adenocarcinoma—ranging from 8% to 18% in some cohorts—have an inherited genetic change (a pathogenic variant) that increased their risk ^[1][2].

Because this percentage is significant, current guidelines recommend that anyone diagnosed with ampullary carcinoma ask to be evaluated for broad germline genetic testing (testing your inherited DNA through blood or saliva) ^[3]. Identifying a pathogenic variant can help guide your treatment—such as determining your eligibility for specific targeted therapies or clinical trials—and provide crucial information for your biological family members ^[4][3].

Connection to Hereditary Syndromes

Ampullary cancer can be associated with several hereditary cancer-predisposition syndromes. A lack of known family history does not rule these out, as families may be small or unaware of past diagnoses.

• Familial Adenomatous Polyposis (FAP): Caused by a variant in the APC gene, FAP causes hundreds of polyps in the colon. It also significantly increases the risk of polyps and cancer in the upper gastrointestinal tract, including the ampulla of Vater ^[5][6].
• Lynch Syndrome: Caused by variants in mismatch repair genes (such as MLH1, MSH2, MSH6, or PMS2), Lynch Syndrome increases the risk for many cancers, particularly colon, uterine, and gastrointestinal cancers, including ampullary cancer ^[7][8].
• DNA-Repair Genes: Ampullary cancer is also linked to variants in hereditary breast, ovarian, pancreatic, and prostate cancer susceptibility genes, such as BRCA1, BRCA2, PALB2, and ATM ^[3][1].

Note: This is not an exhaustive list. A genetics professional will determine which genes belong on your multigene panel based on your specific tumor subtype and family history.

Tumor Testing vs. Germline Testing

Doctors routinely test ampullary tumor tissue for Microsatellite Instability (MSI) or Mismatch Repair Deficiency (dMMR) ^[9][10]. These tests check the tumor for specific DNA repair errors.

While an abnormal MSI/dMMR tumor result can hint at Lynch Syndrome, it does not confirm it. Some tumors acquire these changes sporadically as the cancer grows, rather than from an inherited variant ^[11]. Conversely, a normal tumor result does not completely rule out a hereditary syndrome, because MSI/dMMR testing does not evaluate other genes like BRCA2 or APC. Tumor testing complements, but does not replace, germline testing ^[11].

Testing the Affected Family Member First

When evaluating a family for hereditary cancer, the family member who actually has cancer should generally be tested first ^[12]. Testing the affected person with a multi-gene panel is the most informative way to find out if a disease-associated variant exists in the family.

Understanding Possible Results:

• Positive (Pathogenic Variant): A known disease-causing genetic change was found.
• Variant of Uncertain Significance (VUS): A change was found, but it is currently unknown if it affects health. A VUS should not be used to change your treatment or to test your relatives.
• True Negative: You do not carry the specific pathogenic variant that is already known to run in your family.
• Uninformative Negative: No variant was found on the panel, but if you have a strong family history of cancer or polyposis, a hereditary risk cannot be entirely ruled out.

Do My Children and Relatives Need Testing?

Learning that a cancer is hereditary can bring up feelings of guilt or anxiety about your relatives. If you test positive for a pathogenic variant, each of your biological children and siblings generally has a 50% (1-in-2) chance of inheriting the same variant. However, inheriting a variant increases the risk of cancer; it does not guarantee that cancer will develop.

Whether your relatives should be tested—a process called cascade testing—depends heavily on the specific gene involved ^[12][13]:

• If you test positive for FAP: Because FAP causes polyps very early in life, it is recommended that children of a parent with FAP undergo targeted predictive testing during childhood ^[12][14]. A child carrying the APC variant will need regular surveillance that can detect precancerous polyps early, such as colonoscopies starting around ages 10 to 15, as well as upper-gastrointestinal surveillance later in life ^[15][16].
• If you test positive for Lynch Syndrome or a BRCA-related gene: These are considered adult-onset cancer syndromes. Medical guidelines generally discourage genetic testing for minors in these cases ^[17]. Instead, testing is usually offered when relatives reach adulthood (age 18 or older). The exact age to begin surveillance varies widely depending on the specific gene, sex, and organ involved, so relatives should consult a genetics specialist for personalized timelines ^[18][19].

The Role of Genetic Counseling

Before you or your family members take a genetic test, it is highly recommended to meet with a certified genetic counselor ^[12]. They will review your family tree, coordinate the blood or saliva testing, and help explain the results.

A counselor can also discuss the emotional impact and address privacy concerns. Insurance and genetic discrimination laws vary by country. In the United States, for example, the Genetic Information Nondiscrimination Act (GINA) provides important protections for health insurance and employment, but it generally does not cover life, disability, or long-term care insurance ^[20][21]. Your counselor will help you navigate these local protections so you can make an informed decision. When sharing results with your family, it is best to provide them with a copy of the actual laboratory report or a letter from your genetics clinic, which gives their doctors the exact information needed for cascade testing.